The store will not work correctly when cookies are disabled.
The page will load shortly, Thanks for your patience!
| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source |
| 1. | ALA1047416 | F | Inhibition of Braf in human A375 cells assessed as inhibition of ERK phosphorylation | Homo sapiens | 12 | | cell-based format | Scientific Literature |
| 2. | ALA1047417 | B | Inhibition of recombinant Braf V600E mutant | Homo sapiens | 12 | | assay format | Scientific Literature |
| 3. | ALA1047419 | B | Inhibition of p38alpha | | 12 | | single protein format | Scientific Literature |
| 4. | ALA1047420 | B | Inhibition of KDR | | 12 | | single protein format | Scientific Literature |
| 5. | ALA1047421 | B | Inhibition of LCK | | 12 | | single protein format | Scientific Literature |
| 6. | ALA1047422 | B | Inhibition of Tie2 | | 12 | | single protein format | Scientific Literature |
| 7. | ALA1047423 | A | Elimination half life in Sprague-Dawley rat at 2 mg/kg, iv and 5 mg/kg, po | Rattus norvegicus | 11 | | organism-based format | Scientific Literature |
| 8. | ALA1047424 | A | Clearance in Sprague-Dawley rat at 2 mg/kg, iv and 5 mg/kg, po | Rattus norvegicus | 11 | | organism-based format | Scientific Literature |
| 9. | ALA1047425 | A | Volume of distribution at steady state in Sprague-Dawley rat at 2 mg/kg, iv and 5 mg/kg, po | Rattus norvegicus | 11 | | organism-based format | Scientific Literature |
| 10. | ALA1047426 | A | Oral bioavailability in Sprague-Dawley rat at 5 mg/kg | Rattus norvegicus | 11 | | organism-based format | Scientific Literature |
| 11. | ALA1047427 | A | Elimination half life in CD1 mouse | Mus musculus | 1 | | organism-based format | Scientific Literature |
| 12. | ALA1047428 | A | Clearance in CD1 mouse | Mus musculus | 1 | | organism-based format | Scientific Literature |
| 13. | ALA1047394 | A | Volume of distribution at steady state in CD1 mouse | Mus musculus | 1 | | organism-based format | Scientific Literature |
| 14. | ALA1047395 | A | Oral bioavailability in CD1 mouse | Mus musculus | 1 | | organism-based format | Scientific Literature |
| 15. | ALA1047396 | F | Inhibition of ERK phosphorylation in human A375 SQ2 cells xenografted CD1 mouse at 1 mg/kg, po qd after 6 hrs | Mus musculus | 1 | | organism-based format | Scientific Literature |
| 16. | ALA734643 | F | Inhibition of ERK phosphorylation in human A375 SQ2 cells xenografted CD1 mouse at 2 mg/kg, po qd after 6 hrs | Mus musculus | 1 | | organism-based format | Scientific Literature |
| 17. | ALA1056809 | F | Inhibition of ERK phosphorylation in human A375 SQ2 cells xenografted CD1 mouse at 5 mg/kg, po qd after 6 hrs | Mus musculus | 1 | | organism-based format | Scientific Literature |
| 18. | ALA1056817 | F | Antitumor activity against human A375 SQ2 cells xenografted in CD1 mouse assessed as inhibition of tumor growth at 1 mg/kg, po qd for 14 days | Homo sapiens | 1 | | organism-based format | Scientific Literature |
| 19. | ALA1056818 | F | Antitumor activity against human A375 SQ2 cells xenografted in CD1 mouse assessed as inhibition of tumor growth at 2 mg/kg, po qd for 14 days | Homo sapiens | 1 | | organism-based format | Scientific Literature |
| 20. | ALA1056819 | F | Antitumor activity against human A375 SQ2 cells xenografted in CD1 mouse assessed as regression of tumor growth at 5 mg/kg, po qd for 14 days | Homo sapiens | 1 | | organism-based format | Scientific Literature |